KDIGO
@goKDIGO
KDIGO is a global non-profit foundation dedicated to improving the care and outcomes of people with kidney disease worldwide.
Take the KDIGO Global Guideline Survey! KDIGO is committed to improving outcomes for people with kidney disease, and your insight is essential. The KDIGO Guideline Implementation & Utilization Global Survey aims to understand how clinicians use our guidelines, where they fall…
What does IgA Nephropathy (#IgAN) look like from the perspective of a region where it's most common? In this compelling conversation, Dr. Hong Zhang, Director of the Renal Division at Ping University First Hospital in China, joins former KDIGO CEO John Davis to discuss the…
📣 𝗡𝗘𝗪 𝗧𝗢𝗢𝗟𝗞𝗜𝗧 𝗥𝗘𝗦𝗢𝗨𝗥𝗖𝗘: Get at-a-glance guidance on #ADPKD with our latest infographic, now part of the ISN Rare Kidney Diseases Toolkit! 🔗 lite.spr.ly/6008JeFC Based on the latest @goKDIGO 2025 guidelines, the toolkit highlights diagnostic criteria, risk…
A sample from the pathology teaching slide set on Minimal Change Disease in Adults, jointly prepared by Arkana Laboratories and @goKDIGO. KDIGO.org/guidelines/gd/ #KDIGO #pathology #renal #renalpath
Check out the new KDIGO Direct for the latest updates from KDIGO: kdigo.co/KDIGO-Direct-J… In this issue: - KDIGO Launches Early Career Mentorship Program - CKD Prevention Conference Report Published in Kidney International - KDIGO Holds B Cell Controversies Conference - Take the…
Join us on August 6 as we continue our four-part webinar series, “Confidently Navigating ADPKD: Understanding the New KDIGO Guidelines.” In this session, we’ll explore how ADPKD impacts the heart, liver, bones, and metabolic health. Register today ⬇️ pkdcure-org.zoom.us/webinar/regist…
The plenary session recordings are now available from the KDIGO Controversies Conference on Therapies Targeting B Cells in Immune‑Mediated Kidney Diseases, recently held in Panama City, Panama. Watch the recordings: kdigo.co/B-Cell-Controv… The plenary presentations covered a…
A sample from the pathology teaching slide set on IgA Nephropathy, jointly prepared by Arkana Laboratories and @goKDIGO. KDIGO.org/guidelines/gd/ #KDIGO #pathology #renal #renalpath #pathX
Resistant Membranous Nephropathy: Treatment approach from @goKDIGO #Nephpearls 👉 kdigo.org/guidelines/gd/
Living with IgA Nephropathy (#IgAN)? #NORD invites you to a FREE patient education activity—watch on demand to learn about new #IgANephropathy treatments, clinical guidance, and care strategies for you and your doctor: bit.ly/3T7FeQd Supported by @medliveofficial,…
Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Ortiz, AlbertoAlieri, Enrico et al. Kidney International. kidney-international.org/article/S0085-… @SLANH_ @goKDIGO
What a sparkling meeting on B cell targeting for immune-mediated kidney diseases in Panama! And good to see so many friends and collaborators. Thank you @goKDIGO @BradRovin !
Thanks to @goKDIGO for an amazing weekend learning & discussing with many glomerular diseases experts. Looking for better treatment options for our patients. #KDIGO #PanamaCity #controversies #kidneycare
A sample from the pathology teaching slide set on Membranous Nephropathy, jointly prepared by Arkana Laboratories and @goKDIGO. KDIGO.org/guidelines/gd/ #KDIGO #pathology #renal #renalpath #pathX #kidneypath #pathtwitter
@goKDIGO Implementación y futuro de recomendaciones para el diagnóstico precoz y tratamiento precoz de la ERC #ckd kdigo.co/2025-CKD-Preve…
Preventing chronic kidney disease and maintaining kidney health: conclusions from @goKDIGO Controversies Conference ca. 2025 #Nephpearls 👉🏼 pubmed.ncbi.nlm.nih.gov/40536455/
📢 Registrations are now open for ERA Education - Istanbul 2025! 📆 Join us on September 5-6, 2025, for the second ERA Education Meeting. What you’ll get: 📚Educational sessions 📊Industry symposia & Exhibitions 🎓Certificate of attendance and EACCME®/UEMS credits…
KDIGO is pleased to share the newly published report from its Controversies Conference on Preventing CKD and Maintaining Kidney Health, now available in press in @Kidney_Int. 📄Download the report: kdigo.co/2025-CKD-Preve… 📘 Read the report in KI: kdigo.co/KDIGO-2025-CKD……
📢 Just published: The KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children! An update on steroid-sensitive & -resistant forms, biopsy genetics & more. @goKDIGO #nephrology #pediatrics #glomerular kidney-international.org/article/S0085-…
It’s time to shift from treating CKD to preventing it. The new @goKDIGO report calls for a lifespan approach to kidney health—linking early detection, risk prediction, and proven therapies like #SGLT2i & #GLP1RA. 🩺 Read more: kdigo.org/wp-content/upl…